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Mammographic breast density is clearly a strong risk 
factor for breast cancer [1]. Certain traditional demo­
graphic, behavioral, and genetic risk factors for breast 
cancer have now also been shown to be related to breast 
density [2­7]. A question that therefore naturally arises in 
this context is the extent to which traditional risk factors 
for breast cancer influence breast cancer risk through 
their effects on breast density and the extent to which 
traditional risk factors might operate through other 
pathways. Stated another way, we may be interested in 
the extent to which the effect of traditional risk factors on 
breast cancer is mediated by breast density.
In their review, Boyd and colleagues discuss mediation 
in a number of contexts [7]. They comment that because 
breast density is strongly associated with risk of breast 
cancer, factors that influence density may also contribute 
to the causes of breast cancer. The authors note that 
breast density may be on the causal pathway for breast 
cancer for some or all of the known risk factors. They 
point out that if breast density is to serve as a surrogate 
for breast cancer prevention in intervention trials, then 
most of the effect of such interventions on breast cancer 
risk should be mediated by breast density.
Boyd and colleagues do not, however, discuss how one 
would analytically assess mediation. A very general 
approach has recently been developed to address 
questions of media tion that allows for considerable 
flexibility and can also be applied to case–control studies 
[8]. Let F denote a traditional risk factor, M the percen­
tage mammographic density, B breast cancer, and C a set 
of baseline covariates. The conceptual relation ships 
between these variables are given in Figure  1. If we are 
interested in the extent to which the effect of the risk 
factor is mediated through density (the F–M–B pathway) 
versus the extent to which the effect of the risk factor is 
independent of density (the F–B pathway(s)), we could 
proceed as follows. We could first fit a logistic regression 
model for breast cancer on the risk factor, the percentage 
density, and the baseline covariates:
logit[P(B = 1|F,M,C)] = θ0 + θ1F + θ2M + θ3FM + θ4C
This model allows us to assess the association of breast 
cancer risk with the risk factor of interest and with density. 
Note that this model also allows for potential interaction 
between the risk factor and density, a point to which we 
return below. Second, we could fit a linear regression 
model for density on the risk factor and covariates:
M = β0 + β1F + β2C + ε
If the risk factor is binary, then – under some assump­
tions about confounding control described below  – the 
mediated effect odds ratio is as follows [8]:
Mediated effect = exp(β1θ2 + β1θ3)
The direct effect odds ratio would be:
Direct effect = exp(θ1 + θ3β0 + θ3β2C + θ3θ2σ2 + ½θ32σ2)
where σ2 is the variance of the error term in the linear 
regression model for density. The total effect odds ratio is 
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equal to the product of these direct effect and indirect 
effect odds ratios. The proportion mediated on a log odds 
scale can be calculated by taking the log of the mediated 
effect odds ratio divided by the log of the total effect odds 
ratio. Using a different transformation, the proportion 
mediated on a risk difference scale can also be calculated 
[8].
Expressions for nonbinary exposures and standard 
errors for these effects are given elsewhere [8]. SAS and 
SPSS macros are available to do this automatically; the 
programs and accompanying paper are available from the 
authors upon request and will also be accessible online 
[9].
The expressions above assume that adequate control 
has been made for confounding so that the associations 
from the statistical models reflect causal effects. 
Specifically, the expressions assume that the baseline 
covariates C suffice to control for confounding of the risk 
factor–breast cancer relationship, for confounding of the 
density–breast cancer relationship, and for confounding 
of the risk factor–density relationship. Stated another 
way, our covariates C need to control for the exposure–
outcome, mediator–outcome, and exposure–mediator 
confounders.
The approach above applies to a cohort study if the 
outcome is rare. A modification is necessary for a case–
control study. The same approach would work for a case–
control study with a rare outcome provided that the 
linear regression model for mammographic density is fit 
only amongst the controls. This method takes into 
account the fact that the sample was selected based on 
breast cancer status, and allows the model for the 
mediator to approximate the mediator in the popu la­
tion – provided the breast cancer outcome is rare in the 
population.
The expressions above generalize approaches to 
mediation sometimes employed in the social science 
literature [10] to allow for exposure–mediator interaction 
(that is, interaction between the risk factor and density) 
and to allow for case–control sampling designs. Another 
approach to mediation, more common in epidemiology, 
is to fit the model for the breast cancer outcome both 
with and without the mediator, density (in both cases 
excluding the interaction), and examining whether the 
coefficient for the risk factor changes when the mediator 
is in the model. This is sometimes called the difference 
method. The social science techniques, the difference 
method, and the method described above all make the 
same assumptions about confounding if the direct and 
indirect effects are to be interpreted causally, although 
this is not always explicitly noted when these methods 
are used. The expressions given above, however, general­
ize the difference method approach to allow for 
exposure–mediator interaction.
Including such interactions can be important. For 
example, Boyd and colleagues discuss [7] a prevention 
trial using tamoxifen as an intervention in which, in the 
tamoxifen group, only those who experienced a reduction 
in density had a reduction in breast cancer risk compared 
with the control group; those with tamoxifen but no 
decline in density experienced no risk reduction; and in 
the control group the breast cancer risk was similar in 
subjects with and without breast density reduction [11]. 
In other words, tamoxifen and breast density appear to 
interact in this trial. Boyd and colleagues comment that 
no evidence was given that the change in density 
mediated the effect of tamoxifen on breast cancer risk. 
The methods described above would allow one to assess 
mediation even in the presence of interaction, as seems 
to have indeed been present in this trial.
The methods described above can be used to assess 
mediation in the context of such prevention trials. The 
methods could also be used to assess whether the effect 
of various traditional risk factors (genetic factors, age, 
weight, age at menarche, parity, hormone replacement 
therapy, and so forth) on breast cancer are mediated by 
breast density. Care needs to be taken in appropriate 
confounding control. For any particular risk factor under 
study, one needs to control not only for common causes 
of the risk factor and breast cancer but also for common 
causes of density and breast cancer. Because of the latter 
requirement, control should be made for other risk 
factors that may be related to both density and breast 
cancer, especially if they occur prior to the risk factor 
under study. Control for risk factors subsequent to the 
risk factor under study would be omitted if these also 
serve as mediators for the risk factor of interest. 
Appropriate confounding control is important in the 
analysis of direct and mediated effects. Sensitivity 
analysis techniques can be helpful in assessing the extent 
to which uncontrolled confounding may or may not 
substantially influence estimates [12]. We believe these 
contemporary methods for mediation will be useful in 
Figure 1. Conceptual relationships between variables illustrating 
mediation. Conceptual relationships illustrating mediation between 
a traditional breast cancer risk factor (F), mammographic density (M) 
and breast cancer (B), along with baseline confounding covariates (C).
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shedding further light on the role of mammographic 
density in the etiology of breast cancer.
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density.
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